Malaria is poised for a devastating comeback in Africa’s “worst moment in 25 years”
BMJ 2025; 389 doi: https://doi.org/10.1136/bmj.r783 (Published 25 April 2025) Cite this as: BMJ 2025;389:r783- Frank Burkybile, freelance journalist
- Nairobi
- Burkybile.media{at}gmail.com
In 2000 malaria killed nearly a million people worldwide, with 90% of cases and deaths occurring in Africa. In the decades that followed, an unprecedented global effort—fuelled by billions of dollars in US and other international donor funding—slashed malaria deaths, saving millions of lives. The World Health Organization estimates that 2.2 billion malaria cases and 12.7 million deaths have been averted since 2000. Now, however, that progress is unravelling.
East Africa is facing a triple threat that could undo decades of malaria control efforts: rising drug resistance, the spread of insecticide resistant mosquitoes, and the arrival of a new invasive species, Anopheles stephensi. These threats, emerging against a backdrop of the US government’s abrupt withdrawal of funding for malaria programmes,1 could lead to a deadly resurgence of the disease. Without urgent intervention, experts warn that malaria cases will skyrocket in 2025.
“The thing about malaria is that it resurges quickly,” says Melanie Renshaw, principal director of the African Leaders Malaria Alliance. “When you stop doing malaria prevention, you can quickly see it back to higher levels than before prevention started—even within one malaria season.”
US is key
Malaria is one of humanity’s oldest foes, and history is littered with waves of progress followed by devastating setbacks. From the mosquito infested swamps of ancient Rome to the fever ridden plantations of the Americas, the disease has shaped societies, wars, and economies.
By the early 2000s, the world was seeing a breakthrough. Funding surged as organisations such …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.